Company is increasing production of hospital ventilators and plans to double production within eight weeks as well as achieve a four-fold increase by Q3.
Combines Illumina’s decentralized installed base with Roche’s assay development to provide broad access to clinical oncology next-generation sequencing.
The technology offers a permanent, easily readable and eco-friendly alternative to solvent based printing technologies for medical device applications.